Basic symptoms influence real-life functioning and symptoms in individuals at high risk for psychosis
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Basic symptoms influence real-life functioning and symptoms in individuals at high risk for psychosis. / Glenthøj, L. B.; Bailey, B.; Kristensen, T. D.; Wenneberg, C.; Hjorthøj, C.; Nordentoft, M.
I: Acta Psychiatrica Scandinavica, Bind 141, Nr. 3, 2020, s. 231-240.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Basic symptoms influence real-life functioning and symptoms in individuals at high risk for psychosis
AU - Glenthøj, L. B.
AU - Bailey, B.
AU - Kristensen, T. D.
AU - Wenneberg, C.
AU - Hjorthøj, C.
AU - Nordentoft, M.
N1 - Publisher Copyright: © 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
PY - 2020
Y1 - 2020
N2 - Objective: To investigate potential clinical differences in high-risk profiles presenting with and without basic symptoms, and additionally investigate the association between basic symptoms and clinical symptoms, functioning, and cognition. Methods: High-risk individuals (n = 133) were stratified into individuals fulfilling ultra-high-risk (UHR) criteria (n = 59) and individuals fulfilling UHR+ basic symptoms criteria (BS) (n = 74). Group differences were assessed on clinical symptoms, real-life functioning, and cognition. Regression analyses were conducted to elucidate on the relationship between BS and clinical symptoms, functioning, neurocognition, and social cognition. Results: The group fulfilling both UHR+ BS criteria had significantly more symptoms and lower real-life functioning and quality of life but not more cognitive deficits. BS influenced on attenuated psychotic, depressive, and general symptoms, but only modestly on negative symptoms. No relationship between BS and neuro- and social cognition was established except for an association with emotion recognition processing speed. BS influenced real-life functioning, and this finding was sustained when controlling for the effect of negative symptoms. Conclusions: Our findings indicate that BS contribute highly to the distress and symptom load of clinical high-risk individuals. Longitudinal findings are needed to establish the predictive validity of BS on high-risk individuals’ clinical and functional prognosis.
AB - Objective: To investigate potential clinical differences in high-risk profiles presenting with and without basic symptoms, and additionally investigate the association between basic symptoms and clinical symptoms, functioning, and cognition. Methods: High-risk individuals (n = 133) were stratified into individuals fulfilling ultra-high-risk (UHR) criteria (n = 59) and individuals fulfilling UHR+ basic symptoms criteria (BS) (n = 74). Group differences were assessed on clinical symptoms, real-life functioning, and cognition. Regression analyses were conducted to elucidate on the relationship between BS and clinical symptoms, functioning, neurocognition, and social cognition. Results: The group fulfilling both UHR+ BS criteria had significantly more symptoms and lower real-life functioning and quality of life but not more cognitive deficits. BS influenced on attenuated psychotic, depressive, and general symptoms, but only modestly on negative symptoms. No relationship between BS and neuro- and social cognition was established except for an association with emotion recognition processing speed. BS influenced real-life functioning, and this finding was sustained when controlling for the effect of negative symptoms. Conclusions: Our findings indicate that BS contribute highly to the distress and symptom load of clinical high-risk individuals. Longitudinal findings are needed to establish the predictive validity of BS on high-risk individuals’ clinical and functional prognosis.
KW - cognition
KW - early intervention
KW - psychosis
KW - quality of life
U2 - 10.1111/acps.13117
DO - 10.1111/acps.13117
M3 - Journal article
C2 - 31621062
AN - SCOPUS:85074758949
VL - 141
SP - 231
EP - 240
JO - Acta Psychiatrica Scandinavica
JF - Acta Psychiatrica Scandinavica
SN - 0001-690X
IS - 3
ER -
ID: 262894504